Treatment depends on the disease's manifestations and severity. (1)
Newly diagnosed active, severe PAN should be treated with high-dose glucocorticoids plus cyclophosphamide.
Newly diagnosed, active, non-severe PAN should be treated with glucocorticoids and other immunosuppressive agents, such as azathioprine or methotrexate.
Once remission has been obtained, non-glucocorticoid immunosuppressive agents should be continued for 18 months, alongside tapering of glucocorticoid therapy.
Tumour necrosis factor (TNF) inhibitors appear to be particularly useful in the DADA2 subtype, substantially reducing the risk of stroke.
Control of any hypertension improves prognosis.
1. Chung SA et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of Polyarteritis Nodosa. Available from: https://pubmed.ncbi.nlm.nih.gov/34235883/
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.